• 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • Bur AM Brant JA Mulvey


    [21] Bur AM, Brant JA, Mulvey CL, et al. Association of clinical risk factors and post-operative complications with unplanned hospital readmission after head and neck cancer surgery. JAMA Otolaryngol Head Neck Surg 2016;142(12):1184–90.
    [24] Baschnagel AM, Yadav S, Marina O, et al. Toxicities and costs of placing prophy-lactic and reactive percutaneous gastrostomy tubes in patients with locally ad-vanced head and neck cancers treated with chemoradiotherapy. Head Neck 2014;36(8):1155–61.
    [25] Mays AC, Bartels HG, Wistermayer PR, et al. Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer popu-lation. Head Neck 2018;40(1):111–9.
    [26] Siddiqui AS, Dogar SA, Lal S, Akhtar S, Khan FA. Airway management and post-operative length of hospital stay in patients undergoing head and neck cancer surgery. J Anaesthesiol Clin Pharmacol 2016;32(1):49–53.
    [32] Lowrie EG, Curtin RB, LePain N, Schatell D. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003;41(6):1286–92.
    [33] Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive D-Luciferin failure. Am J Cardiol 1996;78(8):890–5. [34] Ojo B, Genden EM, Teng MS, Milbury K, Misiukiewicz KJ, Badr H. A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol 2012.
    [35] Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? Laryngoscope 2016;126(5):1108–13.
    [36] Seow H, Sussman J, Martelli-Reid L, Pond G, Bainbridge D. Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract 2012;8(6):e142–8.
    [37] Kotronoulas G, Kearney N, Maguire R, et al. What is polyploidy the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 2014;32(14):1480–510.
    [38] Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002;288(23):3027–34.
    [39] Kroenke K, Krebs EE, Wu J, Yu Z, Chumbler NR, Bair MJ. Telecare collaborative management of chronic pain in primary care: a randomized clinical trial. JAMA 2014;312(3):240–8. [40] Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016;34(6):557.
    [41] Lango MN, Egleston B, Fang C, et al. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer 2014;120(6):840–7. [42] American College of Surgeons. User guide for the 2014 American College of Surgeons National Surgical Quality Improvement Program participant use data file; 2015. .
    [43] Graboyes EM, Liou T-N, Kallogjeri D, Nussenbaum B, Diaz JA. Risk factors for unplanned hospital readmission in otolaryngology patients. Otolaryngol Head Neck Surg 2013;149(4):562–71.
    [46] Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the MD Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127(7):870–6.
    [47] Wall LR, Ward EC, Cartmill B, Hill AJ. Physiological changes to the swallowing mechanism following (chemo) radiotherapy for head and neck cancer: a systematic review. Dysphagia 2013;28(4):481–93.